Chlorhexidine locking device for central line infection prevention in ICU patients: protocol for an open-label pilot and feasibility randomized controlled trial

BACKGROUND: Critically ill patients in the intensive care unit (ICU) are at risk for central line-associated bloodstream infection (CLABSI) with an incidence up to 6.9 per 1000 catheter days. CLABSI has a significant attributable mortality and increases in-hospital length of stay, readmissions, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamir, Nasim, Pook, Makena, McDonald, Ellen, Fox-Robichaud, Alison E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027059/
https://www.ncbi.nlm.nih.gov/pubmed/32099661
http://dx.doi.org/10.1186/s40814-020-0564-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027059/
https://www.ncbi.nlm.nih.gov/pubmed/32099661
http://dx.doi.org/10.1186/s40814-020-0564-9

Ejemplares similares